146 related articles for article (PubMed ID: 38371040)
21. COVID-19 pneumonia complicated by bilateral pneumothorax: A case report.
Shirai T; Mitsumura T; Aoyagi K; Okamoto T; Kimura M; Gemma T; Shigematsu T; Takahashi J; Azuma S; Yoshizuka R; Sasaki H; Urushibata N; Ochiai K; Hondo K; Morishita K; Aiboshi J; Otomo Y; Miyazaki Y
Respir Med Case Rep; 2020; 31():101230. PubMed ID: 32999855
[TBL] [Abstract][Full Text] [Related]
22. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.
Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577
[TBL] [Abstract][Full Text] [Related]
23. Severe acute respiratory syndrome coronavirus-2 Alpha variant (B.1.1.7), original wild-type severe acute respiratory syndrome coronavirus 2, and cytomegalovirus co-infection in a young adult with acute lymphoblastic leukemia, case report, and review of the possible cytomegalovirus reactivation mechanisms.
Amanati A; Shahriari M; Bordbar MR; Hedayati SB; Ziyaeyan M; Jamalidoust M; Kalani M; Heydari Marandi N
J Med Case Rep; 2023 Feb; 17(1):66. PubMed ID: 36765433
[TBL] [Abstract][Full Text] [Related]
24. Co-infection of COVID-19 and influenza A in a hemodialysis patient: a case report.
Jing R; Vunnam RR; Schnaubelt E; Vokoun C; Cushman-Vokoun A; Goldner D; Vunnam SR
BMC Infect Dis; 2021 Jan; 21(1):68. PubMed ID: 33441085
[TBL] [Abstract][Full Text] [Related]
25. A 63-Year-Old Man with a Diagnosis of Re-Infection with SARS-CoV-2 Nine Weeks After an Initial Hospital Admission with COVID-19 Pneumonia.
Dudek I; Jesiotr M; Rzeszotarska A; Kłos K; Chciałowski A; Nowak M; Korsak J
Am J Case Rep; 2022 Jan; 23():e932999. PubMed ID: 35073284
[TBL] [Abstract][Full Text] [Related]
26. A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
Chen LD; Li H; Ye YM; Wu Z; Huang YP; Zhang WL; Lin L
BMC Infect Dis; 2020 Jul; 20(1):517. PubMed ID: 32677909
[TBL] [Abstract][Full Text] [Related]
27. Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies.
Hooper AT; Somersan-Karakaya S; McCarthy SE; Mylonakis E; Ali S; Mei J; Bhore R; Mahmood A; Geba GP; Dakin P; Weinreich DM; Yancopoulos GD; Herman GA; Hamilton JD;
mBio; 2022 Dec; 13(6):e0169922. PubMed ID: 36255239
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
29. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.
Hagihara M; Hayashi H; Nakashima S; Imai Y; Nakano H; Uchida T; Inoue M; Sakai-Tagawa Y; Ito M; Yamayoshi S; Iwatsuki-Horimoto K; Suzuki Y; Kawaoka Y
Intern Med; 2024 Jan; ():. PubMed ID: 38171874
[TBL] [Abstract][Full Text] [Related]
30. Prolonged infective SARS-CoV-2 omicron variant shedding in a patient with diffuse large B cell lymphoma successfully cleared after three courses of remdesivir.
Nakamura K; Sugiyama M; Ishizuka H; Sasajima T; Minakawa Y; Sato H; Miyazawa M; Kitakawa K; Fujita S; Saito N; Kashiwabara N; Kohata H; Hara Y; Kanari Y; Shinka T; Kanemitsu K
J Infect Chemother; 2023 Aug; 29(8):820-824. PubMed ID: 37182841
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
32. A case report of super responder of critical COVID-19 pneumonia.
Kishaba T; Maeda A; Fukuoka S; Imai T; Takakura S; Yokoyama S; Shiiki S; Narita M; Nabeya D; Nagano H
J Med Invest; 2021; 68(1.2):192-195. PubMed ID: 33994470
[TBL] [Abstract][Full Text] [Related]
33. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
[TBL] [Abstract][Full Text] [Related]
34. Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD.
Inoue H; Jinno M; Ohta S; Kishino Y; Kawahara T; Mikuni H; Sato H; Yamamoto M; Sato Y; Onitsuka C; Goto Y; Ikeda H; Sato H; Uno T; Uchida Y; Kimura T; Miyata Y; Hirai K; Homma T; Watanabe Y; Kusumoto S; Suzuki S; Tokimatsu I; Tanaka A; Sagara H
Respir Med Case Rep; 2020; 31():101200. PubMed ID: 32868989
[TBL] [Abstract][Full Text] [Related]
35. Late diagnosis of respiratory syncytial virus and influenza co-infection during coronavirus disease 2019 pandemic: a case report.
Barahimi E; Azad MH; Hesarooeyeh ZG; Hafshejani NH; Defaee S; Seddighi N
J Med Case Rep; 2023 Oct; 17(1):437. PubMed ID: 37864237
[TBL] [Abstract][Full Text] [Related]
36. Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised Patients.
Gliga S; Lübke N; Killer A; Gruell H; Walker A; Dilthey AT; Thielen A; Lohr C; Flaßhove C; Krieg S; Pereira JV; Seraphin TP; Zaufel A; Däumer M; Orth HM; Feldt T; Bode JG; Klein F; Timm J; Luedde T; Jensen BO
Clin Infect Dis; 2023 Feb; 76(3):408-415. PubMed ID: 36189631
[TBL] [Abstract][Full Text] [Related]
37. Primary SARS-CoV-2 Pneumonia Screening in Adults: Analysis of the Correlation Between High-Resolution Computed Tomography Pulmonary Patterns and Initial Oxygen Saturation Levels.
Alonazi B; Mostafa MA; Farghaly AM; Zindani SA; Al-Watban JA; Altaimi F; Almotairy AS; Fagiry MA; Mahmoud MZ
Curr Med Imaging; 2022; 19(5):486-493. PubMed ID: 35927895
[TBL] [Abstract][Full Text] [Related]
38. Advances in the Omicron variant development.
Vitiello A; Ferrara F; Auti AM; Di Domenico M; Boccellino M
J Intern Med; 2022 Jul; 292(1):81-90. PubMed ID: 35289434
[TBL] [Abstract][Full Text] [Related]
39. Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant.
Cicchitto G; Cardillo L; de Martinis C; Sabatini P; Marchitiello R; Abate G; Rovetti A; Cavallera A; Apuzzo C; Ferrigno F; Fusco G
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337057
[TBL] [Abstract][Full Text] [Related]
40. Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies.
Vellas C; Del Bello A; Gaube G; Tremeaux P; Jeanne N; Ranger N; Martin-Blondel G; Delobel P; Kamar N; Izopet J
Open Forum Infect Dis; 2022 Apr; 9(4):ofac093. PubMed ID: 35299988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
